About Us

Heart Rhythm Clinical and Research
Solutions

Our focus is the generation of Real World Evidence. We have unique insights on procedure volumes, characteristics, complications and success rates of the sites in our network.

We offer CRO services to a wide spectrum of clients, ranging from large medical device companies to small and mid-size start-ups.

We support pre-market (e.g., IDE) and post-market clinical studies with Clinical Project Management, Data Management, Data Monitoring, Clinical Site Managements etc.

We go beyond just managing studies, we create and manage focused, proprietary networks of physicians and engage them with your products.

A personal journey from practice to innovation

2013 - Where it all started

In 2013, as he left academia and started his career in a private practice in cardiac electrophysiology, Dr. Jose Osorio. realized that the known success and complications rates of most procedures were based on limited and outdated clinical trials, instead of real-world evidence reflecting the diversity of patients.

Dr. Osorio began collecting standardized data from all of his patients resulting in one of the largest real-world outcomes databases on radiofrequency ablation for atrial fibrillation.

2019 - Creation of a complete market solution

In 2019, together with Gunther Schrappe, Dr. Osorio transformed his successful clinical experience into a complete market solution to leverage and decentralize real-world data generation in the healthcare industry.

2020-2021 - Expansion

In 2020 and 2021 the company expanded its client base from one Real World Evidence (RWE) registry to two RWE registries with two leading electrophysiology device companies.

2022 - Expansion / Collaboration with FDA

In 2022, the company continued to expand the number of Real World Evidence registries, going beyond atrial fibrillation and into left atrial appendage closure.

Dr. Paul Varosy, a leader in electrophysiology outcomes research joined our team.

The company also started its first FDA labeling research study using RWE, implemented a retrospective research study to allow a startup to train its AI model and started its first clinical trial with sites in the U.S and Europe.

A personal journey from practice to innovation

2013 - Where it all started

In 2013, as he left academia and started his career in a private practice in cardiac electrophysiology, Dr. Jose Osorio. realized that the known success and complications rates of most procedures were based on limited and outdated clinical trials, instead of real-world evidence reflecting the diversity of patients.

Dr. Osorio began collecting standardized data from all of his patients resulting in one of the largest real-world outcomes databases on radiofrequency ablation for atrial fibrillation.

2019 - Creation of a complete market solution

In 2019, together with Gunther Schrappe, Dr. Osorio transformed his successful clinical experience into a complete market solution to leverage and decentralize real-world data generation in the healthcare industry.

2020-2021 - Expansion

In 2020 and 2021 the company expanded its client base from one Real World Evidence (RWE) registry to two RWE registries with two leading electrophysiology device companies.

2022 - Expansion / Collaboration with FDA

In 2022, the company continued to expand the number of Real World Evidence registries, going beyond atrial fibrillation and into left atrial appendage closure.

Dr. Paul Varosy, a leader in electrophysiology outcomes research joined our team.

The company also started its first FDA labeling research study using RWE, implemented a retrospective research study to allow a startup to train its AI model and started its first clinical trial with sites in the U.S and Europe.

A personal journey from practice to innovation

2013 - Where it all started

In 2013, as he left academia and started his career in a private practice in cardiac electrophysiology, Dr. Jose Osorio. realized that the known success and complications rates of most procedures were based on limited and outdated clinical trials, instead of real-world evidence reflecting the diversity of patients.

Dr. Osorio began collecting standardized data from all of his patients resulting in one of the largest real-world outcomes databases on radiofrequency ablation for atrial fibrillation.

2019 - Creation of a complete market solution

In 2019, together with Gunther Schrappe, Dr. Osorio transformed his successful clinical experience into a complete market solution to leverage and decentralize real-world data generation in the healthcare industry.

2020-2021 - Expansion

In 2020 and 2021 the company expanded its client base from one Real World Evidence (RWE) registry to two RWE registries with two leading electrophysiology device companies.

2022 - Expansion /
Collaboration with FDA

In 2022, the company continued to expand the number of Real World Evidence registries, going beyond atrial fibrillation and into left atrial appendage closure.

Dr. Paul Varosy, a leader in electrophysiology outcomes research joined our team.

The company also started its first FDA labeling research study using RWE, implemented a retrospective research study to allow a startup to train its AI model and started its first clinical trial with sites in the U.S and Europe.

2023 - Consolidation and Expansion

The company’s network grew by 10x from 1Q 2020 to 4Q 2022.

HRCRS is creating a learning health organization in partnership with clinicians, researchers, and other stakeholders.

This includes the formation of special interest groups and regular meetings where best practices are shared and research opportunities are discussed.

As a result, we have seen over 50% of participating physicians change their practice to adopt an innovation presented by one of their peers.

Meet Our Team

2023 - Consolidation and Expansion

The company’s network grew by 10x from 1Q 2020 to 4Q 2022.

HRCRS is creating a learning health organization in partnership with clinicians, researchers, and other stakeholders.

This includes the formation of special interest groups and regular meetings where best practices are shared and research opportunities are discussed.

As a result, we have seen over 50% of participating physicians change their practice to adopt an innovation presented by one of their peers.

Meet our team

2023 - Consolidation and Expansion

The company’s network grew by 10x from 1Q 2020 to 4Q 2022.

HRCRS is creating a learning health organization in partnership with clinicians, researchers, and other stakeholders.

This includes the formation of special interest groups and regular meetings where best practices are shared and research opportunities are discussed.

As a result, we have seen over 50% of participating physicians change their practice to adopt an innovation presented by one of their peers.

Meet our team

Our Numbers

 So far...

10X

Growth of our network in 2 years

50%

Of Physicians changed their practices

120+

Electrophysiologists using our network

3+

New Sites
per Month

Our Numbers

 So far...

10X

Growth of our network in 2 years

50%

Of Physicians changed their practices

120+

Electrophysiologists using our network

3+

New Sites per Month

Our Numbers

 So far...

10X

Growth of our network in 2 years

50%

Of Physicians changed their practices

120+

Electrophysiologists using our network

3+

New Sites per Month

35

States

65+

Signed Data Sharing
Agreements

5

Countries

130+

Electrophysiologists
Using

3+

New Sites per
Month

Global Collaborations in:

Want to see more?

Request our Presentation

35

States

65+

Signed Agreements

5

Countries

130+

Electrophysiologists Using Our Solution

3+

New Sites per Month

Global Collaborations in:

Want to see more?

Request our Presentation

Our Network

35

States

65+

Signed Data Sharing
Agreements

5

Countries

130+

Electrophysiologists
Using Our Solution

3+

New Sites per
Month

Global Collaborations in:

Want to see more?

Request our Presentation

Sites in our network :

  • Are high volume, quality-driven and research-focused
  • Are interested in solving critical questions in the field of electrophysiology, and more specifically, atrial fibrillation ablation
  • Hail from academia and private practice
  • Utilize a consistent standard of care protocol to make research implementation more efficient
Want to see more?
Request our Presentation

Sites in our network :

  • Are high volume, quality-driven and research-focused
  • Are interested in solving critical questions in the field of electrophysiology, and more specifically, atrial fibrillation ablation
  • Hail from academia and private practice
  • Utilize a consistent standard of care protocol to make research implementation more efficient
Want to see more?
Request our Presentation

Sites in our network :

  • Are high volume, quality-driven and research-focused
  • Are interested in solving critical questions in the field of electrophysiology, and more specifically, atrial fibrillation ablation
  • Hail from academia and private practice
  • Utilize a consistent standard of care protocol to make research implementation more efficient
Want to see more?
Request our Presentation
About Us
Solutions
Publications and Abstracts
Contact Us

@hrcrs

© 2013-2023 HRCRS, All Rights Reserved. Version 1.1